About Protein Structure & Engineering
The Protein Structure & Engineering category is part of the AI Drug Discovery market map, tracking 13 companies building in this segment. Target discovery, molecular design, protein folding, and clinical trial optimization accelerating the path from lab to patient. Curated by Hartmann Capital's venture research team.
Companies in Protein Structure & Engineering
- Isomorphic Labs — Seed, $600M
- Generate Biomedicines — Series C, $750M
- Absci — Public, $425M
- EvolutionaryScale — Seed, $142M
- Profluent — Series B, $150M
- Cradle — Series B, $103M
- Dyno Therapeutics — Series A, $109M
- Evozyne — Series B, $144M
- Arzeda — Series B, $33M
- Latent Labs — Series A, $50M
- Monod Bio — Seed, $25M
- Nabla Bio — Seed, $8M
- Adaptyv Bio — Series A, $20M
Frequently Asked Questions
- What companies are in the Protein Structure & Engineering category?
- The Protein Structure & Engineering category includes 13 companies: Isomorphic Labs, Generate Biomedicines, Absci, EvolutionaryScale, Profluent, Cradle, Dyno Therapeutics, Evozyne, Arzeda, Latent Labs, Monod Bio, Nabla Bio, Adaptyv Bio. This is part of the AI Drug Discovery market map maintained by Hartmann Capital.
- How many Protein Structure & Engineering startups are tracked?
- Hartmann Capital tracks 13 companies in the Protein Structure & Engineering segment of the AI Drug Discovery market map.
- What are the best funded Protein Structure & Engineering companies?
- Top funded companies in Protein Structure & Engineering include Generate Biomedicines ($750M), Isomorphic Labs ($600M), Absci ($425M), Profluent ($150M), Evozyne ($144M). Browse the full list in the AI Drug Discovery market map.
- How can I submit my startup?
- You can submit your startup for inclusion by visiting the submission page. Submissions are reviewed by Hartmann Capital's research team.